SCHEMBL4949178

SCHEMBL4949178

Nc1nc(Nc2cccc(O)c2)nc2c1ncn2[C@H]1C[C@@H](O)CO1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.47
KMT2A Q03164 2/20 0.47
ADORA2A P29274 2/20 0.47
ADORA2B P29275 2/20 0.47
THPO P40225 1/20 0.47
MEN1 O00255 1/20 0.47
CYP2D6 P10635 1/20 0.47
CYP2C9 P11712 1/20 0.47
CYP2C19 P33261 1/20 0.47
BLM P54132 1/20 0.47
CHKA P35790 3/20 0.41
PDGFRA P16234 2/20 0.40
PNP P00491 1/20 0.37
LMNA P02545 1/20 0.37
TP53 P04637 1/20 0.37
HTT P42858 1/20 0.37
PDE4D Q08499 1/20 0.37
PDE3A Q14432 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4949185 1.00 CYP1A2 (0.47) CYP1A2KMT2AADORA2AADORA2BTHPO
SCHEMBL4948967 0.80 CYP1A2 (0.49) CYP1A2KMT2AADORA2AADORA2BTHPO
SCHEMBL4948978 0.80 CYP1A2 (0.49) CYP1A2KMT2AADORA2AADORA2BTHPO
SCHEMBL23897429 0.74 AHCY (0.62) ADORA2AADORA2BCHKAPNPLMNA
SCHEMBL5582394 0.70 AHCY (0.60) KMT2AADORA2AADORA2BMEN1CYP2C9
SCHEMBL5582393 0.70 AHCY (0.60) KMT2AADORA2AADORA2BMEN1CYP2C9
SCHEMBL31309583 0.70 AHCY (0.60) KMT2AADORA2AADORA2BMEN1CYP2C9
SCHEMBL22992329 0.70 AHCY (0.60) KMT2AADORA2AADORA2BMEN1CYP2C9
SCHEMBL22762138 0.70 AHCY (0.60) KMT2AADORA2AADORA2BMEN1CYP2C9
SCHEMBL21967677 0.69 FLT3 (0.48) KMT2AMEN1CYP2C9BLMPDGFRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1990054-A1 Polymerase inhibitors and their use in treating tumours Freie Universität Berlin (DE) 2008-11-12 EP disclosed